
Chemical and Pharmaceutical Bulletin p. 84 - 96 (1998)
Update date:2022-08-05
Topics:
Seki, Toshimi
Kanada, Arihiro
Nakao, Tomio
Shiraiwa, Masahumi
Asano, Hajime
Miyazawa, Katuhiko
Ishimori, Tsutomu
Minami, Nobuyoshi
Shibata, Kenyu
Yasuda, Kikuo
Synthesis of the four optical isomers of TZC-5665 (1), a candidate for the treatment of congestive heart failure, was achieved by the reaction of chiral diaminopyridazinone (2) with chiral glycidyl ether (3). The hypotensive and β-blocking activities of 1 and its optical isomers were examined when given intravenously into anesthetized rats. Furthermore these compounds were evaluated for inhibitory activity on cAMP phosphodiesterase III. Among the four optical isomers, R(A),S(B)-one (1c) possessed the essential activities of TZC-5665 (1).
View MoreContact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Doi:10.1021/ja01083a022
(1965)Doi:10.1002/hlca.19680510627
(1968)Doi:10.1021/jo971995f
(1998)Doi:10.1002/anie.201304691
(2013)Doi:10.1039/a707354b
(1998)Doi:10.1016/S0957-4166(97)00617-4
(1998)